Upgrade to SI Premium - Free Trial

Rapport Therapeutics (RAPP)

40.98 -1.80 (4.21%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 Rapport Therapeutics, For: Jul 27 Filed by: Ceesay Abraham July 29, 2026 4:05 PM - SEC Filing William Blair Starts Rapport Therapeutics (RAPP) at Outperform July 27, 2026 4:07 PM - StreetInsider Form 4 Rapport Therapeutics, For: Jul 14 Filed by: Ceesay Abraham July 15, 2026 4:15 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 30 Filed by: Gault Cheryl July 1, 2026 4:10 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 29 Filed by: Ceesay Abraham July 1, 2026 4:05 PM - SEC Filing Form 144 Rapport Therapeutics, Filed by: Gault Cheryl June 30, 2026 4:34 PM - SEC Filing Form 144 Rapport Therapeutics, Filed by: Ceesay Abraham June 29, 2026 4:46 PM - SEC Filing Leerink Starts Rapport Therapeutics (RAPP) at Outperform June 24, 2026 6:10 AM - StreetInsider Form 4 Rapport Therapeutics, For: Jun 10 Filed by: MARAGANORE JOHN June 10, 2026 5:57 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 10 Filed by: PEREZ ROBERT J June 10, 2026 5:52 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 10 Filed by: PAUL STEVEN M June 10, 2026 5:49 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 10 Filed by: Silva Paul M June 10, 2026 5:28 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 10 Filed by: HEALY JAMES June 10, 2026 5:27 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 10 Filed by: Huber Reid M June 10, 2026 5:25 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 10 Filed by: Young Wendy B. June 10, 2026 5:24 PM - SEC Filing Form 4 Rapport Therapeutics, For: Jun 10 Filed by: Sanchez Ramiro June 10, 2026 5:23 PM - SEC Filing Form 8-K Rapport Therapeutics, For: Jun 10 June 10, 2026 4:12 PM - SEC Filing Rapport Therapeutics (RAPP) Reiterated at Market Outperform by Citizens June 2, 2026 4:32 AM - StreetInsider Form 4 Rapport Therapeutics, For: May 26 Filed by: TRV GP VI, LLC May 28, 2026 5:00 PM - SEC Filing Form 144 Rapport Therapeutics, Filed by: Third Rock Ventures V, L.P. May 27, 2026 9:17 AM - SEC Filing Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference May 20, 2026 4:05 PM - StreetInsider Truist Securities Assumes Rapport Therapeutics (RAPP) at Buy May 18, 2026 4:38 PM - StreetInsider Form SCHEDULE 13G/A Rapport Therapeutics, Filed by: Cormorant Asset Management, LP May 15, 2026 1:28 PM - SEC Filing Form 4 Rapport Therapeutics, For: May 11 Filed by: TRV GP VI, LLC May 13, 2026 7:06 PM - SEC Filing Stifel Reiterates Buy Rating on Rapport Therapeutics (RAPP) May 12, 2026 3:00 AM - StreetInsider Form 4 Rapport Therapeutics, For: May 07 Filed by: TRV GP VI, LLC May 11, 2026 5:07 PM - SEC Filing Form 144 Rapport Therapeutics, Filed by: Third Rock Ventures V, L.P. May 11, 2026 4:26 PM - SEC Filing Form 144 Rapport Therapeutics, Filed by: Third Rock Ventures V, L.P. May 8, 2026 4:58 PM - SEC Filing Rapport Therapeutics (RAPP) PT Raised to $57 at Goldman Sachs May 8, 2026 6:43 AM - StreetInsider Form 144 Rapport Therapeutics, Filed by: Third Rock Ventures V, L.P. May 7, 2026 4:44 PM - SEC Filing Raymond James Reiterates Strong Buy Rating on Rapport Therapeutics (RAPP) May 7, 2026 8:56 AM - StreetInsider Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.42 May 7, 2026 7:44 AM - StreetInsider Form 10-Q Rapport Therapeutics, For: Mar 31 May 7, 2026 7:31 AM - SEC Filing Form 8-K Rapport Therapeutics, For: May 07 May 7, 2026 7:15 AM - SEC Filing Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update May 7, 2026 7:00 AM - Globe NewsWire Full Article List